Hans de Jong

1.1k total citations
14 papers, 823 citations indexed

About

Hans de Jong is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Hans de Jong has authored 14 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Hans de Jong's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Molecular Biology Techniques and Applications (5 papers). Hans de Jong is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Molecular Biology Techniques and Applications (5 papers). Hans de Jong collaborates with scholars based in Netherlands, United States and Belgium. Hans de Jong's co-authors include Jack A. Schalken, Inge M. van Oort, Sander A. Jannink, G.H.J.M. Leyten, Christina A. Hulsbergen‐van de Kaa, Erik B. Cornel, Frank Smit, Daphne Hessels, Ben C. Knipscheer and H. Vergunst and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Hans de Jong

12 papers receiving 812 citations

Peers

Hans de Jong

PRM

RHEUM

SURGE

G.H.J.M. Leyten Netherlands

Petrea Hodge United States

Martijn P.M.Q. van Gils Netherlands

Ina L. Deras United States

Amina Ali United States

A. Partin United States

Intan P.E.D. Kümmerlin Netherlands

Keefe Murphy Ireland

Chris Bangma Netherlands

Alan W Partin United States

G.H.J.M. Leyten Netherlands

Hans de Jong

623 ×1.0

PRM

369 ×1.1

359 ×1.3

61 ×0.8

RHEUM

66 ×1.0

SURGE

Citations per year, relative to Hans de Jong Hans de Jong (= 1×) peers G.H.J.M. Leyten

Countries citing papers authored by Hans de Jong

Since Specialization

Citations

This map shows the geographic impact of Hans de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans de Jong more than expected).

Fields of papers citing papers by Hans de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans de Jong. The network helps show where Hans de Jong may publish in the future.

Co-authorship network of co-authors of Hans de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Hans de Jong. A scholar is included among the top collaborators of Hans de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans de Jong. Hans de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Jong, Hans de, Frank Smit, Jason C. Poole, et al.. (2024). Discovery of RNA Biomarkers for Prostate Cancer Using Cross-Platform Transcriptomics. International Journal of Molecular Sciences. 25(22). 11907–11907. 1 indexed citations

Jong, Hans de, et al.. (2022). Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer. Prostate Cancer and Prostatic Diseases. 25(3). 583–589. 12 indexed citations

Hendriks, Rianne J., Bas Israël, Gerjon Hannink, et al.. (2021). Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men. Prostate Cancer and Prostatic Diseases. 24(4). 1110–1119. 60 indexed citations

Jong, Hans de, et al.. (2020). Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis. Cancers. 12(12). 3790–3790. 18 indexed citations

Hessels, Daphne, Hans de Jong, Sander A. Jannink, et al.. (2017). Analytical validation of an mRNA-based urine test to predict the presence of high-grade prostate cancer. SHILAP Revista de lepidopterología. 2(1). 6 indexed citations

Neste, Leander Van, Rianne J. Hendriks, Siebren Dijkstra, et al.. (2016). Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score. European Urology. 70(5). 740–748. 257 indexed citations

Hendriks, Rianne J., Siebren Dijkstra, Erik B. Cornel, et al.. (2016). Elevated HOXC6/DLX1 mRNA biomarker levels in urine to help select patients at increased risk for high-grade prostate cancer detection upon prostate biopsy.. Journal of Clinical Oncology. 34(2_suppl). 31–31. 2 indexed citations

Leyten, G.H.J.M., Daphne Hessels, Frank Smit, et al.. (2015). Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer. Clinical Cancer Research. 21(13). 3061–3070. 164 indexed citations

Dijkstra, Siebren, G.H.J.M. Leyten, Sander A. Jannink, et al.. (2014). KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment. The Prostate. 74(12). 1222–1230. 27 indexed citations

10.

Leyten, G.H.J.M., Daphne Hessels, Sander A. Jannink, et al.. (2014). 351 QUATTRO, a four gene prognostic biomarker panel for prostate cancer. European Urology Supplements. 13(1). e351–e351. 1 indexed citations

11.

Leyten, G.H.J.M., Daphne Hessels, Sander A. Jannink, et al.. (2012). Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer. European Urology. 65(3). 534–542. 268 indexed citations

12.

Leyten, G.H.J.M., Daphne Hessels, Erik B. Cornel, et al.. (2012). 2104 PROSPECTIVE MULTICENTER EVALUATION OF PCA3 AND TMPRSS2-ERG GENE FUSIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR PROSTATE CANCER. The Journal of Urology. 187(4S). 4 indexed citations

13.

Jong, Hans de, et al.. (2011). Validation of Unmanned Aircraft Systems' Integration into the Airspace (VUSIL I and II). SAE International Journal of Aerospace. 4(2). 1216–1227.

14.

Jong, Hans de, et al.. (1999). Het betrekken van de omgeving bij de behandeling van de borderlinepatiënt. 1(1). 19–24. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact